HOME >> MEDICINE >> NEWS
UM outreach programs increase kidney transplants among African-Americans

Transplant surgeons at the University of Maryland Medical Center say they have successfully reduced barriers to kidney transplantation for African-Americans to cut the median waiting time for transplant in half. Their achievement stems from a comprehensive program that includes patient education and efforts to increase living donation and improve overall kidney graft survival. Results of their decade-long strategy are being presented today (April 25) at the American Surgical Association national meeting in Hot Springs, Virginia.

Lead author of the report, Clarence E. Foster, III, M.D., a transplant surgeon at the University of Maryland Medical Center, says African-American patients now have a median waiting time of 681 days to receive a transplant at the medical center. Nationally, according to the United Network for Organ Sharing (UNOS) database, African-Americans wait about 1,335 days.

African-Americans encounter several barriers to kidney transplantation. Doctors traditionally have been less likely to suggest transplantation to their African-American patients because of lower rates of kidney survival and a higher rate of acute organ rejection, says Dr. Foster, who is also an assistant professor of surgery at the University of Maryland School of Medicine.

As a result, African-Americans are less likely to be referred for transplant, they are placed on transplant lists less often after evaluation and end up waiting much longer because fewer organs are available that are a good match, adds Dr. Foster.

The University of Maryland Medical Center has the largest kidney transplant program in the United States. During the past ten years, over 2,100 kidney transplants have been performed. Forty-three percent of the Maryland transplants were in African-Americans, significantly more than the UNOS-computed national average of 32 percent.

Stephen T. Bartlett, M.D., director of Transplant Surgery at the University o
'"/>

Contact: Bill Seiler
bseiler@umm.edu
410-328-8919
University of Maryland Medical Center
25-Apr-2002


Page: 1 2 3

Related medicine news :

1. NYU Child Study Center and The Bear Stearns Charitable Foundation launch outreach campaign
2. NIMH expands national outreach partnership
3. Opponents of needle-exchange programs should think about their message to drug users
4. School-based smoking prevention programs ineffective
5. NHLBI study shows smoking cessation programs improve survival
6. Physicians call for increased funding for federal infectious disease programs
7. UC Irvines undergraduate research programs receive $900,000 funding boost
8. Longer cardiac rehab programs necessary, says U of T study
9. PENN study emphasizes need for national guidelines for assisted reproductive technology programs
10. Dana-Farber receives CDC grants to develop health promotion/prevention programs in the work place
11. Study questions safety of heart procedures at hospitals without cardiac surgery programs

Post Your Comments:
(Date:4/23/2014)... "simple and accessible detection methods that can rapidly ... of a single cell inside that population has ... Chang Lu. , In the Royal Society of ... announced that he and his coworkers have developed ... of a protein ( Chem. Sci. , 2014, ...
(Date:4/23/2014)... are often displayed in the popular Swedish children,s ... of high-sugar foods. A new study from the ... in children,s TV programmes as well as the ... and weight status. , Steingerdur Olafsdottir,s doctoral thesis ... popular Swedish children,s TV show Bolibompa. Healthy foods ...
(Date:4/23/2014)... led by a researcher from the Cancer Science Institute ... Singapore has identified the cancer specific stem cell which ... of developing new drugs for the treatment of this ... group, led by Dr Chan Shing Leng, Research Assistant ... that a cancer-specific variant of a cell surface protein, ...
(Date:4/23/2014)... in the journal Oncotarget , explored tumour ... or their own DNA signatures within the same ... design effective, targeted treatment strategies. , Firstly they ... and either the KRAS or BRAF mutation. Secondly, ... EGFR gene mutation have that specific mutation present ...
(Date:4/23/2014)... Alzheimer,s disease has been a rapidly evolving pursuit ... latest crook in the research road, scientists have ... proteins associated with the disease. The report, which ... , could have important implications for developing novel ... colleagues explain that for years, research has suggested ...
Breaking Medicine News(10 mins):Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:High-calorie and low-nutrient foods in kids' TV 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Forecast and Market Analysis to 2022 ... Atopic Dermatitis - India Drug Forecast and ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a ... needs of severely obese patients, today announced initial ... a selective inhibitor of methionine aminopeptidase 2 (MetAP2), ... form of genetic obesity.  These results showed improvements ...
(Date:1/14/2014)... InformEx, North America,s leading business partnering ... the 30 th edition of its annual conference at ... January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... and specialty chemical companies will take part in the conference, ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: